On June 23, Brownstein’s Health Care industry group convened a roundtable of health care professionals and experts to discuss the health care business climate during and post COVID-19. The discussion includes trends across different health care sectors, an update from Brownstein’s Washington, D.C. team, False Claims Act issues associated with COVID-19 economic stimulus monies, the business and deal making environment and risks specific the health care industry, antitrust issues that could arise, as well as updates on the current state of the industry from medical professionals.
Panelists:
Moderator: Mike King, shareholder at Brownstein Hyatt Farber Schreck
Erin Eiselein, shareholder at Brownstein Hyatt Farber Schreck
Emily Felder, senior policy advisor and counsel at Brownstein Hyatt Farber Schreck
Alex Geier, senior health care banker at GLC Advisors & Co.
Jason Ficken, founding partner at Quadriga Partners
Allen Grunes, shareholder at Brownstein Hyatt Farber Schreck
Dr. Elizabeth Hawk, faculty at Stanford School of Medicine and president at Ampersand Intelligence
Dr. Robert Bray, founder and director of DISC